Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome
Clinical trial NCT06261502 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06261502
- Sponsor
- Université de Sherbrooke
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.